An artificial pancreas developed by researchers at the University of Cambridge has been granted approval by the U.S. Food and ...
By Adria Calatayud Roche Holding said the U.S. Food and Drug Administration granted priority review to the company's new drug application for inavolisib as ...
Insmed said its experimental drug to treat a type of chronic lung disease helped significantly reduce respiratory symptoms ...
Genovate Biotechnology Co., Ltd. (TPEx: 4130), a Taiwan-based specialty pharmaceutical company, today announced its plans to submit a New Drug Application (NDA) with the United States Food and Drug ...
You could even save on auto insurance! Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental ...
The White House drug czar seems to be overemphasizing the impacts of the Biden administration's decision to reschedule ...
Contrary to his suggestion, nothing about the rescheduling action would specifically address racial disparities in criminal ...
We all know that the last of the Food and Drug Administration’s Food Safety Modernization Act (FSMA) 11 rules, the Food ...
Shares of Insmed Inc. skyrocketed Tuesday, after the biopharmaceutical company said it plans to file a New Drug Application ...
Instead of blaming advocacy groups, we should reform the FDA’s approval process to ensure rigorous scientific evidence is ...
An artificial pancreas developed by researchers at the University of Cambridge has been granted approval by the USA’s Food ...
After reporting positive clinical trial results for its drug brensocatib, Insmed plans to later this year file for U.S. approval in bronchiectasis that’s not associated with cystic fibrosis.